SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

OptimizeRx Corporation (OPRX) News

Follow OptimizeRx Corporation (OPRX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 15 public stories across 8 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol OPRX Asset equity Sector Markets 90 days 10 Last 7.34 Updated Nov 11, 2026, 10:08 PM UTC Open live news feed Open OPRX chart & news
H OptimizeRx Shares Tumble on Cut to Outlook, Despite 3Q Beat By Elias SchisgallShares of OptimizeRx tumbled after the company cut its guidance, even as its third-quarter results exceeded analyst expectations.The stock was down 21% at $7.11 in after-hours trading on Wednesday. Shar EQUITY | Nov 11, 2026, 10:08 PM UTC M OptimizeRx Q3 Sales Fall; Company Lowers Annual Revenue Outlook OptimizeRx reported lower Q3 sales on contracted revenue and lowered its annual revenue outlook. EQUITY | Nov 11, 2026, 09:14 PM UTC L OPTIMIZERX SHARES DROP 13.1% IN EXTENDED TRADING AFTER POSTING QUARTERLY RESULTS OPTIMIZERX SHARES DROP 13.1% IN EXTENDED TRADING AFTER POSTING QUARTERLY RESULTS EARNINGS | Nov 11, 2026, 09:03 PM UTC L B. Riley Securities maintains Buy rating on OptimizeRx, $11 price target B. Riley Securities maintained their Buy rating on OptimizeRx's stock with a price target of $11.00.The price target implies an upside of 40.8% from the Sep 28 close of $7.81.Key takeaways from the analyst noteStrong Mar EQUITY | Sep 29, 2026, 03:55 PM UTC M OptimizeRx integrates authenticated EHR point-of-care inventory with OpenPath OptimizeRx says its authenticated EHR point-of-care inventory will become accessible to advertisers on The Trade Desk via OpenPath, expanding reach to 800,000 verified HCPs. Availability is expected in Q4 2026. EQUITY | Sep 22, 2026, 12:04 PM UTC L OPRX - OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath OPRX - OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath NEWS | Sep 22, 2026, 12:01 PM UTC L OPRX - OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference OPRX - OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference EQUITY | Sep 08, 2026, 11:30 AM UTC L OptimizeRx adds Troy Sarich to advisor board OptimizeRx said experienced pharma and healthcare executive Troy Sarich joined its advisory board to help accelerate innovation and strengthen life sciences marketing technology. EQUITY | Sep 02, 2026, 11:37 AM UTC L OptimizeRx appoints Troy Sarich as co-advisor OptimizeRx appointed Troy Sarich as co advisor. EQUITY | Sep 02, 2026, 11:30 AM UTC L OptimizeRx appoints Troy Sarich as company advisor OptimizeRx appoints pharma commercial and AI expert Troy Sarich as a company advisor. EQUITY | Sep 02, 2026, 11:30 AM UTC L OptimizeRx Affirms FY2026 Sales Guidance OptimizeRx affirms FY2026 sales outlook of $95-100 million EARNINGS | Aug 12, 2026, 08:22 PM UTC L OptimizeRx Announces Finance Leadership Appointments OptimizeRx announces finance leadership appointments to support growth MNA | Aug 12, 2026, 08:05 PM UTC L OptimizeRx Reports Q2 2026 Results OptimizeRx reports second quarter 2026 financial results and updates fiscal year 2026 guidance EARNINGS | Aug 12, 2026, 08:01 PM UTC L OptimizeRx Sets Q2 Call OptimizeRx sets Q2 earnings call EARNINGS | Jul 29, 2026, 11:30 AM UTC M OPRX Launches NLAB OptimizeRx launches Natural Language Audience Builder for life sciences DSPs and agency media planning platforms EQUITY | Jun 25, 2026, 11:30 AM UTC